Chris Viehbacher
Chris Viehbacher (born 1960) is a German-Canadian businessman.[1][2][3][4] He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.[2][3][4]
Biography
Early life
Chris Viehbacher was born on March 26, 1960.[4] He graduated from Queen's University in Kingston, Ontario, Canada.[1][3][4] He is a certified public accountant, and he speaks French, German and English.[1][3][4]
Career
He started his career at PriceWaterhouseCoopers.[1][3][4] In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years.[1][3] Until October 29 2014, he served as CEO of Sanofi and Chairman of Genzyme.[3][4]
He was Chairman of the Pharmaceutical Research and Manufacturers of America from December 2010 to April 2012.[2][3][4] He has been Chair of the CEO Roundtable on Cancer since February 2011.[3][4] He is a member of The Business Roundtable and the International Business Council.[3] He sits on the Board of Directors of Research America and the Burroughs Wellcome Fund.[2] He will serve as President of the European Federation of Pharmaceutical Industries and Associations from June 2013 onwards.[2][3]
In 2003, he became a Knight in the Legion of Honour.[3] In 2012, he received the Pasteur Foundation Award.[3] He sits on the Board of Visitors of the Fuqua School of Business at Duke University.[3]
Personal life
He is married and has three children, including a son. [4]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Christopher Viehbacher: Executive Profile & Biography - Businessweek
- ↑ 2.0 2.1 2.2 2.3 2.4 Christopher Viehbacher - Forbes
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 http://en.sanofi.com/investors/corporate_governance/corporate_management/bio_viehbacher.aspx Sanofi
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 Christopher A. Viehbacher | CEO Roundtable on Cancer